• Ticker

DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

Evotec AG

NASDAQOTH:EVTCY.PK

$5.44 $0.00 (0.00%)

Quote as of

Evotec to offer antibody discovery and development services to 4-Antibody

RapidFire Added to Evotec Labs

Evotec Becomes The First Contract Research Facility In Europe To Offer Agilent's RapidFire/MS Screening For Pharmaceutical Drug Discovery

Evotec Becomes the First Contract Research Facility in Europe to Offer Agilent's RapidFire/MS Scree

Evotec Becomes the First Contract Research Facility in Europe to Offer Agilent's RapidFire/MS Screening for Pharmaceutical Drug Discovery

Evotec, 4-Antibody Ink Antibody Deal

Evotec Reports Continued Strong Revenue Growth in Q1 2012

Evotec AG and 4-Antibody AG Form Strategic Collaboration to Innovate Antibody Selection

Evotec signs 60 million euro deal with China's Conba

Evotec Extends Active Biotech Agreement

Active Biotech AB, Evotec extend/expand medicinal chemistry collaboration

Evotec and Active Biotech Extend and Expand Medicinal Chemistry Collaboration

Forland Selects Kongsberg Evotec ROV System

ROV Launch/Recovery System Chosen for Subsea Vessel

Breakthrough for new Kongsberg Evotec Bulk Hose Securing Unit

Evotec FY 2011: Significant Growth and Focused Investments Drive Profitability and Innovation

Evotec AG: Fiscal Year 2011 Results Presentation on 20 March 2012 Live on the Internet

Cell-Based Assays: World Market Prospects 2012-2022

Evotec And IR Pharma Establish Drug Discovery Alliance In The Field Of Respiratory

Evotec and IR Pharma Establish Drug Discovery Alliance in the Field of Respiratory

Evotec Completes Squeeze-Out Process for DeveloGen

Evotec, Harvard Partner to Study Kidney Disease

Evotec and Harvard University Expand Strategic Alliance into Kidney Disease

Evotec and Harvard University Expand Strategic Alliance Into Kidney Disease

Evotec Receives 4th Milestone Payment in 2011 as Part of Its Discovery Alliance With Boehringer Ingelheim

Evotec Reports Nine Months Results: Upside Materialising

Evotec to Report Third Quarter Results on 10 November 2011

Evotec Achieves Two Milestones in Fragment-based Drug Discovery Alliance With Shionogi

Evotec and APEIRON Biologics Start Next Project on the Cbl-b Target

Roche Targets Anadys Pharma - Analyst Blog

Roche Targets Anadys Pharma

UCB selects Evotec again as discovery partner

Evotec Announces Second Multi-target Collaboration With UCB - Update

Evotec Announces Second Multi-Target Collaboration With UCB

Kongsberg Concludes Acquisition of Evotec AS

Evotec Takes Over Full Ownership of JV in India for 1.7M

Evotec acquires remaining 30% of Indian Joint Venture from DIL

Evotec Acquires Remaining 30% of Indian Joint Venture From DIL

Roche and Evotec Sign Agreement - Analyst Blog

Roche and Evotec Sign Agreement

See More Articles...